Agenus (AGEN)
(Delayed Data from NSDQ)
$5.09 USD
-0.19 (-3.60%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $5.07 -0.02 (-0.39%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Agenus Inc. [AGEN]
Reports for Purchase
Showing records 121 - 140 ( 260 total )
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Expanding Manufacturing Ability to Hasten Development Programs; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Positive on Fundamentals But Awaiting Clarity on Timelines; Lowering PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
QS-21 Monetization: More Than Meets the Eye; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Positive CHMP Opinion Increases QS-21 Monetization Potential; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
CEACAM1 Acquisition to Complement CPM Platform; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Assuming Coverage of Three Unique Plays in Oncology
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
The Immunotherapy Revolution Marches On; Impressions From ASCO 2015
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
On the Road to Curing Cancer: Recent Developments and Future Outlook
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
2015 ASCO Planner-Clinical Data to Keep -Da Bears- AwayThis report contains brief updates on the following: ADXS, AGEN, ARIA, CLSN, CTIC, HTBX, ONTY, SGEN, SPPI, STML, TGTX, THLD. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: BENJAMIN R
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
1Q15 Update-Adding SECANT Is Not Going Off on a Tangent; Raising PT
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: BENJAMIN R
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
2015 AACR Meeting Highlights-Cancer Gets a Dose of Brotherly Love
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: BENJAMIN R
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
4Q14 Update-CPMs Prove to be an ''''Incyteful'''' Investment
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: BENJAMIN R
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Checkpoint Antibody Program Attracts a New Partner and Leaves Room for More
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: BENJAMIN R
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Phase 3 Shingles Vaccine Success Raises the Roof for QS-21 Adjuvant
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: BENJAMIN R
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
Company: Agenus Inc.
Industry: Medical - Biomedical and Genetics
3Q14 Update; Advancing Multiple Checkpoint Modulators to the Finish Line
Provider: H.C. WAINWRIGHT & CO., INC.